17238-56-1

Basic information

• Product Name: bis(pyrrolidine-1-carboxamidine) sulphate
• Synonyms: bis(pyrrolidine-1-carboxamidine) sulphate;bis-(Pyrrolidine-1-carboxamidine) sulfate;Bis(pyrrolidine-1-carboximidamide);sulfuric acid salt
• CAS NO: 17238-56-1
• Molecular Formula: C10H24N6O4S
• Molecular Weight: 324.40036
• EINECS: 241-272-2
• Mol File: 17238-56-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 541.9°Cat760mmHg
• Flash Point: 281.5°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 3.52E-13mmHg at 25°C
• CAS DataBase Reference: bis(pyrrolidine-1-carboxamidine) sulphate(CAS DataBase Reference)
• NIST Chemistry Reference: bis(pyrrolidine-1-carboxamidine) sulphate(17238-56-1)
• EPA Substance Registry System: bis(pyrrolidine-1-carboxamidine) sulphate(17238-56-1)

Safety Data

• Hazardous Substances Data: 17238-56-1(Hazardous Substances Data)

Usage

InChI:InChI=1/2C5H11N3.H2O4S/c2*6-5(7)8-3-1-2-4-8;1-5(2,3)4/h2*1-4H2,(H3,6,7);(H2,1,2,3,4)

Upstream product

• 123-75-1 pyrrolidine 
• 29427-58-5 O-methylisourea hemisulfate 
• 867-44-7 S-Methylisothiourea sulfate 
• 147895-43-0 S-methylisothiourea hemisulphate 

Downstream Products

• 29874-77-9 2-(N-Pyrrolidinyl)-4-chinazolon 
• 284680-44-0 6-methyl-2-(pyrrolidin-1-yl)pyrimidin-4(3H)-one 

Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES

The present invention relates to new compounds that are useful in the prevention or treatment of respiratory diseases, such as asthma, to the preparation of the compounds, and to compositions including the compounds. The present invention also relates to the use of the compounds, as well as compositions including the compounds, in treating or preventing respiratory diseases.

Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents

A novel series of potent pyrazolo[1,5-a]pyridine inhibitors of herpes simplex virus 1 replication have been identified. Several complimentary synthetic methods were developed to allow facile access to a diverse set of analogs from common late stage interm